Matches in SemOpenAlex for { <https://semopenalex.org/work/W2002528361> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W2002528361 endingPage "S647" @default.
- W2002528361 startingPage "S647" @default.
- W2002528361 abstract "For some patients who have adjacent or in-field recurrence following stereotactic body radiotherapy (SBRT) for spinal tumors, repeat SBRT is a reasonable option. With this approach, small volumes of the spinal cord or cauda equina (SC/CE) may be exposed to cumulative doses that exceed its tolerance. Using simple addition of individual endpoints from each plan and cumulative endpoints from a composite plan, we studied the differences in cumulative dose assessment for the SC/CE and its potential clinical implications. We studied 10 consecutive patients who underwent repeat SBRT with in-field or adjacent recurrence after initial SBRT. Cumulative doses were calculated either by adding dosimetric endpoints from the two treatment plans or by creating a voxel by voxel composite dose plan via rigid image registration using MIM Software v5.1. For each treatment, the adjacent SC/CE was contoured as organs at risk (OAR) on MRI and CT images with 3 mm cranial and caudal extensions. The overlap region of the SC/CE between the two treatment plans was also contoured as an independent structure (OAR overlap). Merged SC/CE was defined as the combination of the OAR contours from each of the two treatment plans. Dosimetric endpoints included maximum point dose (MPD), D0.1cc, V10Gy and V12Gy. For each plan, the following dose constraints were clinically accepted: 14 Gy MPD and V10 < 10% for the spinal cord (SC) and 16 Gy MPD and V12 < 10% for the cauda equina (CE). Wilcoxon signed-rank test was used to assess differences between these dosimetric endpoints. The median time to retreatment was 109 days (range, 6 - 427) and the median follow-up was 9.2 months (3.8 - 25.5). No Grade 3 or 4 toxicities were observed. Compared to the composite plan, the simple addition method overestimated the MPD and D0.1cc of both the OAR overlap (23.1 Gy vs. 18.9 Gy, p = 0.001 and 19.1 Gy vs. 15.5 Gy, p = 0.001, respectively) and the merged SC/CE (24.5 Gy vs. 20.0 Gy, p = 0.006 and 21.6 Gy vs. 16.3 Gy, p = 0.01, respectively). In contrast, the V10 and V12 were underestimated for the merged SC (8.2% vs. 25.2%, p = 0.03) and the merged CE (11.0% vs. 32.0%, p = 0.06), respectively. Composite MPD of OAR overlap exceeded clinical dose constraints for patients treated near the CE (mean = 21.9 Gy, p = 0.03), but not near the SC (mean = 15.9 Gy, p = 0.15). One patient developed a foot drop. Her composite MPD was 28.6 Gy and D0.1cc was 27.9 Gy to the OAR overlap while the V12 of the CE was 16%. Retreatment with SBRT for adjacent or in-field retreatment of spinal metastases is relatively safe. However, attention must be paid to the cumulative dose parameters from the composite dose plan because simple endpoint addition of two plans may lead to inaccurate estimation of the actual cumulative dose to the OARs." @default.
- W2002528361 created "2016-06-24" @default.
- W2002528361 creator A5001335930 @default.
- W2002528361 creator A5011221111 @default.
- W2002528361 creator A5029857725 @default.
- W2002528361 creator A5046981277 @default.
- W2002528361 creator A5047255532 @default.
- W2002528361 creator A5058440874 @default.
- W2002528361 creator A5087295298 @default.
- W2002528361 date "2011-10-01" @default.
- W2002528361 modified "2023-10-14" @default.
- W2002528361 title "3D Composite Dose is Necessary to Assess Cumulative Spinal Cord Dose for Retreatment of Spinal Tumors with Stereotactic Body Radiotherapy" @default.
- W2002528361 doi "https://doi.org/10.1016/j.ijrobp.2011.06.1910" @default.
- W2002528361 hasPublicationYear "2011" @default.
- W2002528361 type Work @default.
- W2002528361 sameAs 2002528361 @default.
- W2002528361 citedByCount "1" @default.
- W2002528361 countsByYear W20025283612018 @default.
- W2002528361 crossrefType "journal-article" @default.
- W2002528361 hasAuthorship W2002528361A5001335930 @default.
- W2002528361 hasAuthorship W2002528361A5011221111 @default.
- W2002528361 hasAuthorship W2002528361A5029857725 @default.
- W2002528361 hasAuthorship W2002528361A5046981277 @default.
- W2002528361 hasAuthorship W2002528361A5047255532 @default.
- W2002528361 hasAuthorship W2002528361A5058440874 @default.
- W2002528361 hasAuthorship W2002528361A5087295298 @default.
- W2002528361 hasBestOaLocation W20025283611 @default.
- W2002528361 hasConcept C118552586 @default.
- W2002528361 hasConcept C126838900 @default.
- W2002528361 hasConcept C151032500 @default.
- W2002528361 hasConcept C201645570 @default.
- W2002528361 hasConcept C2780387249 @default.
- W2002528361 hasConcept C2780775167 @default.
- W2002528361 hasConcept C2781300204 @default.
- W2002528361 hasConcept C2989005 @default.
- W2002528361 hasConcept C509974204 @default.
- W2002528361 hasConcept C54170458 @default.
- W2002528361 hasConcept C71924100 @default.
- W2002528361 hasConceptScore W2002528361C118552586 @default.
- W2002528361 hasConceptScore W2002528361C126838900 @default.
- W2002528361 hasConceptScore W2002528361C151032500 @default.
- W2002528361 hasConceptScore W2002528361C201645570 @default.
- W2002528361 hasConceptScore W2002528361C2780387249 @default.
- W2002528361 hasConceptScore W2002528361C2780775167 @default.
- W2002528361 hasConceptScore W2002528361C2781300204 @default.
- W2002528361 hasConceptScore W2002528361C2989005 @default.
- W2002528361 hasConceptScore W2002528361C509974204 @default.
- W2002528361 hasConceptScore W2002528361C54170458 @default.
- W2002528361 hasConceptScore W2002528361C71924100 @default.
- W2002528361 hasIssue "2" @default.
- W2002528361 hasLocation W20025283611 @default.
- W2002528361 hasOpenAccess W2002528361 @default.
- W2002528361 hasPrimaryLocation W20025283611 @default.
- W2002528361 hasRelatedWork W1121435541 @default.
- W2002528361 hasRelatedWork W1500316510 @default.
- W2002528361 hasRelatedWork W1995337141 @default.
- W2002528361 hasRelatedWork W2017051941 @default.
- W2002528361 hasRelatedWork W2031173265 @default.
- W2002528361 hasRelatedWork W2070741266 @default.
- W2002528361 hasRelatedWork W2088990335 @default.
- W2002528361 hasRelatedWork W2102963139 @default.
- W2002528361 hasRelatedWork W3209760499 @default.
- W2002528361 hasRelatedWork W4307145805 @default.
- W2002528361 hasVolume "81" @default.
- W2002528361 isParatext "false" @default.
- W2002528361 isRetracted "false" @default.
- W2002528361 magId "2002528361" @default.
- W2002528361 workType "article" @default.